JAZZ PHARMACEUTICALS FRANCE
- Country
- π«π·France
- Ownership
- -
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder
- Conditions
- First Posted Date
- 2005-04-01
- Last Posted Date
- 2008-01-09
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 158
- Registration Number
- NCT00106860
- Locations
- πΊπΈ
Midwest Clinical Research Center, Dayton, Ohio, United States
πΊπΈIPS Research Company, Oklahoma City, Oklahoma, United States
πΊπΈOregon Center for Clinical Research, Inc., Eugene, Oregon, United States
Experimental Medication For the Treatment of Generalized Anxiety Disorder
- Conditions
- First Posted Date
- 2004-11-30
- Last Posted Date
- 2014-10-03
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 511
- Registration Number
- NCT00097708
- Locations
- πΊπΈ
Princeton Medical Institute, Princeton, New Jersey, United States
πΊπΈPharmasite Research, Inc., Baltimore, Maryland, United States
πΊπΈSouthwestern Research Institute, Burbank, California, United States
Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia
- Conditions
- Interventions
- First Posted Date
- 2004-07-14
- Last Posted Date
- 2012-01-24
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 195
- Registration Number
- NCT00087555
- Locations
- πΊπΈ
Wallace Rheumatic Study Center, Los Angeles, California, United States
πΊπΈRadiant Research, Inc., West Palm Beach, Florida, United States
πΊπΈC.A.R.E. Center, Raleigh, North Carolina, United States
Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients
- Conditions
- Interventions
- First Posted Date
- 2004-07-01
- Last Posted Date
- 2012-02-24
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT00086281
- Locations
- π¨π¦
London Health Sciences Centre, Victoria Campus, London, Ontario, Canada
πΊπΈClinical Research Group of St. Petersburg, St. Petersburg, Florida, United States
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
- Conditions
- Interventions
- First Posted Date
- 2003-08-06
- Last Posted Date
- 2011-12-29
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 231
- Registration Number
- NCT00066170
- Locations
- πΊπΈ
The Center for Sleep and Wake Disorders/Midwest Neurology, Danville, Indiana, United States
πΊπΈClinical Research Group of St. Petersburg, Inc., St. Petersburg, Florida, United States
π©πͺPsychiatrische Universitatsklinik, Regensburg, Germany